Research / ACCS / Fundamental state Inspectable configuration
State dimensions Filing 0001654954-24-013940 General Corporate
Debt relative to revenue RAW Current state valid · history insufficient
Evidence method Level · gp.fundamentals.debt_to_revenue
238.65% · OPTIONAL · NOT_ENOUGH_HISTORY
Capex intensity 10th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.capex_revenue_ratio
0.04% · OPTIONAL · VALID
Operating cash generation 60th Own-history percentile · N=20
Evidence method Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue
21.54% · OPTIONAL · VALID
Revenue growth 10th Own-history percentile · N=20
Evidence method Yoy · gp.fundamentals.revenue
-8.14% · CORE · VALID
Gross margin 45th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.gross_margin
74.39% · CORE · VALID
Operating margin 5th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.operating_margin
2.24% · CORE · VALID
R&D intensity 100th Own-history percentile · N=20
Evidence method Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue
9.65% · OPTIONAL · VALID
SBC intensity 85th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.sbc_revenue_ratio
3.85% · OPTIONAL · VALID
As-filed lineage Fundamental state history Each observation is tied to the filing and facts available at that report date. Amendments remain separate.
History 70 states Self-history eligible
Sep 30, 2021 7/7 normalized Level 3 Dec 31, 2021 7/7 normalized Level 3 Mar 31, 2022 7/7 normalized Level 3 Jun 30, 2022 7/7 normalized Level 3 Sep 30, 2022 7/7 normalized Level 3 Dec 31, 2022 7/7 normalized Level 3 Mar 31, 2023 7/7 normalized Level 3 Jun 30, 2023 7/7 normalized Level 3 Sep 30, 2023 7/8 normalized Level 3 Dec 31, 2023 7/8 normalized Level 3 Mar 31, 2024 7/8 normalized Level 3 Jun 30, 2024 7/8 normalized Level 3 Sep 30, 2024 7/8 normalized Level 3 Dec 31, 2024 6/7 normalized Level 3 Mar 31, 2025 7/8 normalized Level 3 Jun 30, 2025 7/8 normalized Level 3 Sep 30, 2025 8/8 normalized Level 3 Dec 31, 2025 8/8 normalized Level 3 Mar 31, 2026 8/8 normalized Level 3 Jun 30, 2026 8/8 normalized Level 4 Period transition
What moved in the state? Balance Sheet Leverage Increased
Previous 233.15%
Current 238.65%
Delta 5.50% Capex Intensity Increased
Previous 0.00%
Current 0.04%
Delta 0.04% Cash Generation Increased
Previous -2.47%
Current 21.54%
Delta 24.02% Growth Increased
Previous -20.35%
Current -8.14%
Delta 12.21% Margin Decreased
Previous 76.78%
Current 74.39%
Delta -2.39% Profitability Decreased
Previous 4.34%
Current 2.24%
Delta -2.10% R And D Intensity Increased
Previous 9.35%
Current 9.65%
Delta 0.30% Sbc Intensity Increased
Previous 3.47%
Current 3.85%
Delta 0.38% Self-history only Previous similar states Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.
Not enough compatible prior states for a transparent self-history match.
Research Graph
Related governed research Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.